PKC inhibition results in a Kv1.5 + Kvβ1.3 pharmacology closer to Kv1.5 channels. (5th September 2014)
- Record Type:
- Journal Article
- Title:
- PKC inhibition results in a Kv1.5 + Kvβ1.3 pharmacology closer to Kv1.5 channels. (5th September 2014)
- Main Title:
- PKC inhibition results in a Kv1.5 + Kvβ1.3 pharmacology closer to Kv1.5 channels
- Authors:
- Macías, A
de la Cruz, A
Prieto, A
Peraza, D A
Tamkun, M M
González, T
Valenzuela, C - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="bph12822-sec-0001" sec-type="section"> <title>Background and Purpose</title> <p>The K<sub>v</sub>β1.3 subunit modifies the gating and pharmacology of K<sub>v</sub>1.5 channels in a PKC‐dependent manner, decreasing channel sensitivity to bupivacaine‐ and quinidine‐mediated blockade. Cardiac K<sub>v</sub>1.5 channels associate with receptor for activated C kinase 1 (RACK1), the K<sub>v</sub>β1.3 subunit and different PKC isoforms, resulting in the formation of a functional channelosome. The aim of the present study was to investigate the effects of PKC inhibition on bupivacaine and quinidine block of K<sub>v</sub>1.5 + K<sub>v</sub>β1.3 channels.</p> </sec> <sec id="bph12822-sec-0002" sec-type="section"> <title>Experimental Approach</title> <p>HEK293 cells were transfected with K<sub>v</sub>1.5 + K<sub>v</sub>β1.3 channels, and currents were recorded using the whole‐cell configuration of the patch‐clamp technique. PKC inhibition was achieved by incubating the cells with either calphostin C or bisindolylmaleimide II and the effects of bupivacaine and quinidine were analysed.</p> </sec> <sec id="bph12822-sec-0003" sec-type="section"> <title>Key Results</title> <p>The voltage‐dependent inactivation of K<sub>v</sub>1.5 + K<sub>v</sub>β1.3 channels and their pharmacological behaviour after PKC inhibition with calphostin C were similar to those displayed by K<sub>v</sub>1.5 channels alone.<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="bph12822-sec-0001" sec-type="section"> <title>Background and Purpose</title> <p>The K<sub>v</sub>β1.3 subunit modifies the gating and pharmacology of K<sub>v</sub>1.5 channels in a PKC‐dependent manner, decreasing channel sensitivity to bupivacaine‐ and quinidine‐mediated blockade. Cardiac K<sub>v</sub>1.5 channels associate with receptor for activated C kinase 1 (RACK1), the K<sub>v</sub>β1.3 subunit and different PKC isoforms, resulting in the formation of a functional channelosome. The aim of the present study was to investigate the effects of PKC inhibition on bupivacaine and quinidine block of K<sub>v</sub>1.5 + K<sub>v</sub>β1.3 channels.</p> </sec> <sec id="bph12822-sec-0002" sec-type="section"> <title>Experimental Approach</title> <p>HEK293 cells were transfected with K<sub>v</sub>1.5 + K<sub>v</sub>β1.3 channels, and currents were recorded using the whole‐cell configuration of the patch‐clamp technique. PKC inhibition was achieved by incubating the cells with either calphostin C or bisindolylmaleimide II and the effects of bupivacaine and quinidine were analysed.</p> </sec> <sec id="bph12822-sec-0003" sec-type="section"> <title>Key Results</title> <p>The voltage‐dependent inactivation of K<sub>v</sub>1.5 + K<sub>v</sub>β1.3 channels and their pharmacological behaviour after PKC inhibition with calphostin C were similar to those displayed by K<sub>v</sub>1.5 channels alone. Indeed, the IC<sub>50</sub> values for bupivacaine were similar in cells whose PKC was inhibited with calphostin C or bisindolylmaleimide II. Similar results were also observed in the presence of quinidine.</p> </sec> <sec id="bph12822-sec-0004" sec-type="section"> <title>Conclusions and Implications</title> <p>The finding that the voltage‐dependence of inactivation and the pharmacology of K<sub>v</sub>1.5 + K<sub>v</sub>β1.3 channels after PKC inhibition resembled that observed in K<sub>v</sub>1.5 channels suggests that both processes are dependent on PKC‐mediated phosphorylation. These results may have clinical relevance in diseases that are characterized by alterations in kinase activity.</p> </sec> </abstract> … (more)
- Is Part Of:
- British journal of pharmacology. Volume 171:Number 21(2014:Nov.)
- Journal:
- British journal of pharmacology
- Issue:
- Volume 171:Number 21(2014:Nov.)
- Issue Display:
- Volume 171, Issue 21 (2014)
- Year:
- 2014
- Volume:
- 171
- Issue:
- 21
- Issue Sort Value:
- 2014-0171-0021-0000
- Page Start:
- 4914
- Page End:
- 4926
- Publication Date:
- 2014-09-05
- Subjects:
- Pharmacology -- Periodicals
Chemotherapy -- Periodicals
Drug Therapy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://bibpurl.oclc.org/web/21844 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=282&action=archive ↗
http://onlinelibrary.wiley.com/ ↗
http://www.nature.com/bjp/index.html ↗ - DOI:
- 10.1111/bph.12822 ↗
- Languages:
- English
- ISSNs:
- 0007-1188
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2314.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3010.xml